Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/14/2007 | EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
11/14/2007 | EP1854487A2 Combinations of an 11-beta-hydroxysteroid dehaydrogenase type 1 inhibitor and a glucocorticoid receptor agonist |
11/14/2007 | EP1854486A2 Utilisation of neurotransmitter derivatives for manufacturing agents for treating neuroendocrinal diseases |
11/14/2007 | EP1854485A1 Preventives/remedies for cancer |
11/14/2007 | EP1854484A1 Pain remedy containing rock inhibitor |
11/14/2007 | EP1854483A1 Agent for control of function of antigen-presenting cell |
11/14/2007 | EP1854482A1 Agent for control of degranulation reaction and cytokine production |
11/14/2007 | EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient |
11/14/2007 | EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist |
11/14/2007 | EP1854466A1 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate |
11/14/2007 | EP1854464A2 Combinations comprising epothilone derivatives |
11/14/2007 | EP1854454A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
11/14/2007 | EP1853349A1 Composition for treating mental health disorders |
11/14/2007 | EP1853317A2 Compositions and methods for treating or preventing flaviviridae infections |
11/14/2007 | EP1853316A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
11/14/2007 | EP1853315A1 Treatment for mucositis |
11/14/2007 | EP1853270A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
11/14/2007 | EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone |
11/14/2007 | EP1853220A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use |
11/14/2007 | EP1696909B1 Benzothiazole derivatives for the treatment of diabetes |
11/14/2007 | EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation |
11/14/2007 | EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors |
11/14/2007 | EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
11/14/2007 | EP1423012B1 Medical use of stem cells expressing vegfr-1 |
11/14/2007 | EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
11/14/2007 | EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases |
11/14/2007 | EP1317238B1 Compositions containing a vitamin c component and pigment |
11/14/2007 | EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament |
11/14/2007 | EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
11/14/2007 | EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties |
11/14/2007 | EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof |
11/14/2007 | EP1102593B1 Prostate formula |
11/14/2007 | EP1091735B1 Improved enriched platelet wound healant |
11/14/2007 | EP1003783B1 Lipoprotein-regulating medicaments |
11/14/2007 | EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality |
11/14/2007 | CN101070344A G-csf receptor agonist antibodies and screening method therefor |
11/14/2007 | CN101069746A Composition containing sugar-reducing medicine and antiplatelet medicine |
11/14/2007 | CN101069745A Sugar-reducing medicine composition |
11/14/2007 | CN101069685A Solid drug for oral use |
11/14/2007 | CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent |
11/14/2007 | CN101069660A Biliary-tract carriage carrying about medicine and preparing method therefor |
11/14/2007 | CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
11/14/2007 | CN100348265C Controlled release composition and method of producing the same |
11/14/2007 | CN100348183C Medium chain fatty acids applicable as anitmicrobial agents |
11/13/2007 | US7294652 Autoimmune conditions and NADPH oxidase defects |
11/13/2007 | US7294651 Inhibition of exoprotein production using isoprenoid compositions |
11/13/2007 | US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye |
11/13/2007 | US7294480 High throughput screening assays using fatty acid synthetic enzymes |
11/13/2007 | US7294476 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta . |
11/13/2007 | US7294455 Fixed-dried platelets cross-linked to protein |
11/13/2007 | US7294339 Method for treating allodynia by peripheral administration of a neurotoxin |
11/13/2007 | US7294337 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies |
11/13/2007 | US7294334 Methods and compositions to treat myocardial conditions |
11/13/2007 | US7294332 Combination therapy (temozolomide and α-IFN) for advanced cancer |
11/13/2007 | CA2431586C Antibiotic/benzoyl peroxide dispenser |
11/13/2007 | CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof |
11/13/2007 | CA2396159C Novel substituted benzimidazole dosage forms and method of using same |
11/13/2007 | CA2383715C Improving condition of elderly pets |
11/13/2007 | CA2292965C Pyrrolidine derivative hair growth compositions and uses |
11/13/2007 | CA2285574C Method and composition for treating sleep apnea |
11/13/2007 | CA2253257C Receptor for underivatized, aqueous soluble .beta.(1-3)-glucan |
11/08/2007 | WO2007127667A1 Augmentation of titer for vaccination in animals |
11/08/2007 | WO2007127377A2 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease |
11/08/2007 | WO2007126455A2 Method for using boc/cdo to modulate hedgehog signaling |
11/08/2007 | WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity |
11/08/2007 | WO2007126104A1 Method of predicting skin spot formation and method of screening skin spot formation inhibitor with the use of spot site-increasing genes as indication |
11/08/2007 | WO2007125883A1 Composition for improvement in sleep quality |
11/08/2007 | WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet |
11/08/2007 | WO2007125310A2 Pharmaceutical combinations of pk inhibitors and other active agents |
11/08/2007 | WO2007103427A3 Medical use of bilirubin and its structural analogues |
11/08/2007 | WO2007096601A3 Antimicrobial formulations comprising a quinone and a copper salt |
11/08/2007 | WO2007092590A3 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa) |
11/08/2007 | WO2007072221A3 Surface marker-directed cancer therapeutics |
11/08/2007 | WO2006120360A3 Active composition for treatment or prevention of problems related to a disturbance of the biological clock |
11/08/2007 | WO2006085983A3 Viral adjuvants |
11/08/2007 | US20070259890 Compounds and Compositions as Ppar Modulators |
11/08/2007 | US20070259824 identifying a substance that down-regulates an immune response in an animal, comprising determining whether substance inhibits an interaction between factors in the CD26 signaling pathway, wherein substance inhibits the interaction between CD26 and caveolin-1 |
11/08/2007 | US20070259813 Anti-Bacterial Composition Especially for Controlling Gram-Negative Bacteria, Comprising a Peptide and an Advantageously Hydrophobic Anti-Bacterial Agent |
11/08/2007 | US20070259811 Method of modulating the proliferation of medullary thyroid carcinoma cells |
11/08/2007 | US20070259400 Antibodies |
11/08/2007 | US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture |
11/08/2007 | US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
11/08/2007 | US20070259050 Combined Cosmetic or Therapeutic Preparation |
11/08/2007 | US20070259007 Lactoferrin: an adjuvant for vaccines |
11/08/2007 | US20070258991 Immunogenic agent therapy using plasmapheresis |
11/08/2007 | US20070258984 Anti-neoplastic composition of 5-FU, leucovorin, irinotecan, oxaliplatin, capecitabine, paclitaxel or doxetaxel; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer |
11/08/2007 | US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof |
11/08/2007 | US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand |
11/08/2007 | US20070258961 Cholesterol efflux and uses thereof |
11/08/2007 | US20070258960 Stabilized products, process and devices for preparing same |
11/08/2007 | US20070258958 Interactive wound cover |
11/08/2007 | US20070258951 Methods of treating cardiac disorders |
11/08/2007 | US20070258943 Genetically engineered cells for therapeutic applications |
11/08/2007 | DE102006020604A1 Flüssige Arzneimittelformulierung Liquid pharmaceutical formulation |
11/08/2007 | CA2650775A1 Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress |
11/08/2007 | CA2650607A1 Compositions and methods for the treatment of cardiovascular disease |
11/08/2007 | CA2650572A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
11/08/2007 | CA2650341A1 Augmentation of titer for vaccination in animals |
11/08/2007 | CA2647939A1 Methods and compositions for vaccination of poultry |
11/08/2007 | CA2647277A1 Method for using boc/cdo to modulate hedgehog signaling |